It’s hormone optimization and midlife health. At the organization where I serve as chief medical officer, we’ve treated ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...

Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction in the ris ...

Vaping has often been marketed as a “cleaner” alternative to smoking, but new health concerns continue to stack up fast. One ...

Most men think fertility is a yes or no question. You can have kids, or you can’t. The reality is much more interesting and ...

NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced results from the final analysis of the Phase 3 PROTEUS study, evaluating apalutamide plus hormone therapy (androgen deprivation therapy, ADT ...

Improved radiographic progression-free survival (rPFS) regardless of disease volume or metastatic presentation achieved with ...

Menopause is universal, but women around the world don't always experience it the same way. Here's what culture, stress, lifestyle, and modern life may reveal.

Johnson & Johnson's JNJ.N prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the cancer and reduced the ...

Lemme, the award-winning wellness brand co-founded by Kourtney Kardashian Barker, introduces Lemme Balance Capsules, an ...

Research in mice reveals a new way that brain plasticity is controlled — providing a long-awaited insight into how critical ...